interleukin-1beta (163-171) has been researched along with isoflurane in 1 studies
| Studies (interleukin-1beta (163-171)) | Trials (interleukin-1beta (163-171)) | Recent Studies (post-2010) (interleukin-1beta (163-171)) | Studies (isoflurane) | Trials (isoflurane) | Recent Studies (post-2010) (isoflurane) |
|---|---|---|---|---|---|
| 192 | 3 | 74 | 9,723 | 2,117 | 2,666 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alper, M; Bedirli, A; Bedirli, N; Kerem, M; Ofluoglu, E; Ozlu, O; Pasaoglu, H; Utebey, G; Yilmazer, D | 1 |
1 other study(ies) available for interleukin-1beta (163-171) and isoflurane
| Article | Year |
|---|---|
Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model.
Topics: Adenosine Triphosphate; Alanine Transaminase; Anesthetics, Inhalation; Animals; Aspartate Aminotransferases; Blood Flow Velocity; Cytokines; Disease Models, Animal; Energy Metabolism; Interleukin-1beta; Isoflurane; Lipid Peroxidation; Liver; Liver Circulation; Male; Malondialdehyde; Methyl Ethers; Peptide Fragments; Rats; Rats, Wistar; Reperfusion Injury; Sevoflurane; Time Factors; Tumor Necrosis Factor-alpha | 2008 |